expires March 2021 • Irbesartan HCTZ, 150 mg/12.5mg 30 count, lot number 325D18004, expires March 2021 • Irbesartan HCTZ, 150 mg/12.5 mg, 90 count, lot number 325B18004, expires March ...

It's recalling: All batches of irbesartan tablets USP 75mg, 150mg and 300mg All batches of irbesartan and hydrochlorothiazide tablets USP, 150mg/12.5mg and 300mg/12.5mg Lupin says it received four ...

All batches of Irbesartan tablets in 75 mg, 150 mg and 300 mg strengths and Irbesartan and Hydrochlorothiazide tablets in 150 mg/12.5 mg and 300 mg/12.5 mg strengths made by Lupin Pharmaceuticals ...

Out of an abundance of caution, Lupin is recalling all batches of Irbesartan Tablets USP 75mg, 150mg and 300mg and Irbesartan and Hydrochlorothiazide Tablets USP, 150mg/12.5mg and 300mg/12.5mg in ...

Each group was divided into two subgroups receiving either irbesartan (150 mg b.i.d. orally) or placebo for 60 days. After 15 days of washout, irbesartan was given to the subgroups who had ...

and patients who provided consent were randomly assigned to receive irbesartan once daily (at a dose of 150 mg per day for 2 weeks, and 300 mg per day thereafter) or placebo. Assignment was ...

Irbesartan (Sebri 150 mg) is an angiotensin II receptor blocker (ARB), prescribed for high blood pressure either alone or combined with other medications. It is also used to treat kidney disorders ...

Patients were started on 75 mg of irbesartan or placebo once daily. The dose was doubled to 150 mg after 1 to 2 weeks and was doubled again to 300 mg after an additional 1 to 2 weeks, according to ...

"Although Lupin has received no reports of illness that appear to relate to this issue, the company, out of an abundance of caution, is recalling all batches of Irbesartan Tablets USP 75mg, 150mg ...